like your optimism but Neurons hard work is only focused at Neurondevelopmental disorders the ones who speak of is Neurodegenative diseases . if a company did manage to achieve results in the latter, well that would be the holy grail.
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial, page-20
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.09 |
Change
0.080(0.47%) |
Mkt cap ! $2.184B | |||
| Open | High | Low | Value | Volume |
| $17.38 | $17.54 | $16.84 | $10.33M | 602.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1361 | $17.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.22 | 1425 | 1 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |